About Index Trending news
Lists
Pricing
miRagen Therapeutics

miRagen Therapeutics

miRagen Therapeutics

miRagen is a clinical stage biopharmaceutical company developing innovative microRNA-targeting therapies to improve human health.

Elsewhere

Alexa global traffic share

Twitter followers

Latest funding Show all
Employees

Team size

10+
Locations
HQ
$40,000,000 Venture capital (Series D)
PE Hub

Miragen racks up $40 mln, will merge with Signal Genetics